| 1 |
Abaah D, Ohene LA, Adjei CA. Physical and social wellbeing of family caregivers of persons with hepatitis B associated chronic liver disease in Ghana: a qualitative study. BMC Prim Care 2023;24:82. [PMID: 36964491 DOI: 10.1186/s12875-023-02041-5] [Reference Citation Analysis]
|
| 2 |
Farshadpour F, Taherkhani R, Farajzadeh H. Hepatitis B infection among β-thalassemia major patients in Bushehr province of southern Iran. J Immunoassay Immunochem 2023;44:147-61. [PMID: 36587831 DOI: 10.1080/15321819.2022.2163178] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 3 |
Lawrence P, Chabane M, Abrouk L, Thiesson A, Berthé D, Diarra AB, Bengaly K, Traoré B, Kassogué D, Durand G, Voegele C, Le Calvez-Kelm F, Steenkeste N, Hainaut P, Kouriba B, Gormally E. First Molecular Characterization of Chronic Hepatitis B Carriers in Timbuktu, Mali. Diagnostics (Basel) 2023;13. [PMID: 36766478 DOI: 10.3390/diagnostics13030375] [Reference Citation Analysis]
|
| 4 |
Mohamed AA, Esmail OE, Ibrahim AMA, Makled S, Al-Hussain E, Elsaid A, Alboraie M, El-Awady RR. The role of PRDM1 gene polymorphism in the progression of hepatocellular carcinoma in Egyptian patients. J Med Virol 2023;95:e28343. [PMID: 36424348 DOI: 10.1002/jmv.28343] [Reference Citation Analysis]
|
| 5 |
Arga KY, Kori M. Current status of viral biomarkers for oncogenic viruses. Oncogenic Viruses 2023. [DOI: 10.1016/b978-0-12-824156-1.00009-1] [Reference Citation Analysis]
|
| 6 |
Kori M, Arga KY. Human oncogenic viruses: an overview of protein biomarkers in viral cancers and their potential use in clinics. Expert Rev Anticancer Ther 2022;22:1211-24. [PMID: 36270027 DOI: 10.1080/14737140.2022.2139681] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Ullah K, Dogar AW, Ochani S, Jobran AWM, Nisar H, Nazar MW. Implementation of World Health Organization Global Hepatitis Program for Eliminating Hepatitis B Infection Globally. Asia Pac J Public Health 2022;34:877-8. [PMID: 36000166 DOI: 10.1177/10105395221121047] [Reference Citation Analysis]
|
| 8 |
Sa I, K E, B AB, M G, S EA, I B, R H, B A. Post-vaccine immunity against hepatitis B in Moroccan children. J Adv Pediatr Child Health 2022;5:028-032. [DOI: 10.29328/journal.japch.1001049] [Reference Citation Analysis]
|
| 9 |
Abouqal R, Beji M, Chakroun M, Marhoum El Filali K, Rammaoui J, Zaghden H. Trends in Adult and Elderly Vaccination: Focus on Vaccination Practices in Tunisia and Morocco. Front Public Health 2022;10:903376. [DOI: 10.3389/fpubh.2022.903376] [Reference Citation Analysis]
|
| 10 |
El-kassas M, Elbadry M. Hepatocellular Carcinoma in Africa: Challenges and Opportunities. Front Med 2022;9:899420. [DOI: 10.3389/fmed.2022.899420] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 11 |
Bahnacy A, Ghonaim M, El Hosiny EM, Gadallah AA. Occult Hepatitis (B) Infection in Hepatitis (C) Virus Infection Patients after the Treatment with Direct Acting Antiviral Drugs. Open Access Maced J Med Sci 2022;10:2529-2535. [DOI: 10.3889/oamjms.2022.7799] [Reference Citation Analysis]
|
| 12 |
Tadesse M, Tafesse G, Hajare ST, Chauhan NM. Assessment of Prevalence of Hepatitis B Virus and its Associated Factors among Pregnant Women from Wolaita Sodo, Ethiopia. Journal of Clinical Virology Plus 2022. [DOI: 10.1016/j.jcvp.2022.100069] [Reference Citation Analysis]
|
| 13 |
Hormati A, Hajrezaei Z, Jazi K, Aslani Kolur Z, Rezvan S, Ahmadpour S. Gastrointestinal and Pancratohepatobiliary Cancers: A Comprehensive Review on Epidemiology and Risk Factors Worldwide. Middle East J Dig Dis 2022;14:5-23. [PMID: 36619733 DOI: 10.34172/mejdd.2022.251] [Reference Citation Analysis]
|
| 14 |
Abd El-halim JA, Gewaifel GI, Darwish EAF, Ramadan AM, Elsisi GH. Health care resources utilization and costs associated with different clinical stages of chronic hepatitis B in Egypt. Egypt Liver Journal 2021;11. [DOI: 10.1186/s43066-021-00162-z] [Reference Citation Analysis]
|
| 15 |
Rungta S, Kumari S, Verma K, Akhtar G, Deep A Sr, Swaroop S. A Comparative Analysis of the APRI, FIB4, and FibroScan Score in Evaluating the Severity of Chronic Liver Disease in Chronic Hepatitis B Patients in India. Cureus 2021;13:e19342. [PMID: 34909303 DOI: 10.7759/cureus.19342] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 16 |
Harputluoglu M, Carr BI. Hepatitis B Before and After Hepatocellular Carcinoma. J Gastrointest Cancer 2021. [PMID: 34762265 DOI: 10.1007/s12029-021-00745-4] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 17 |
Philips CA, Ahamed R, Abduljaleel JK, Rajesh S, Augustine P. Critical Updates on Chronic Hepatitis B Virus Infection in 2021. Cureus 2021;13:e19152. [PMID: 34733599 DOI: 10.7759/cureus.19152] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 18 |
Athamneh RY, Arıkan A, Sayan M, Mahafzah A, Sallam M. Variable Proportions of Phylogenetic Clustering and Low Levels of Antiviral Drug Resistance among the Major HBV Sub-Genotypes in the Middle East and North Africa. Pathogens 2021;10:1333. [PMID: 34684283 DOI: 10.3390/pathogens10101333] [Reference Citation Analysis]
|
| 19 |
Elbahrawy A, Ibrahim MK, Eliwa A, Alboraie M, Madian A, Aly HH. Current situation of viral hepatitis in Egypt. Microbiol Immunol 2021;65:352-72. [PMID: 33990999 DOI: 10.1111/1348-0421.12916] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 20 |
Stawinska-Witoszynska B, Klos J, Moryson W, Wieckowska B. Trends in the Incidence of Acute Hepatitis B in the Polish Population and Their Determinants. Medicina (Kaunas) 2021;57:738. [PMID: 34440944 DOI: 10.3390/medicina57080738] [Reference Citation Analysis]
|
| 21 |
Yang X, Siddique A, Khan AA, Wang Q, Malik A, Jan AT, Rudayni HA, Chaudhary AA, Khan S. Chlamydia Trachomatis Infection: Their potential implication in the Etiology of Cervical Cancer. J Cancer 2021;12:4891-900. [PMID: 34234859 DOI: 10.7150/jca.58582] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 22 |
Caligaris G, Trunfio M, Ghisetti V, Cusato J, Nigra M, Atzori C, Imperiale D, Bonora S, Di Perri G, Calcagno A. Blood-Brain Barrier Impairment in Patients Living with HIV: Predictors and Associated Biomarkers. Diagnostics (Basel) 2021;11:867. [PMID: 34065785 DOI: 10.3390/diagnostics11050867] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 23 |
Mohamed AA, Abd-elsalam S, El-daly MM, Kamal N, Saed SM, Mohamoud S, Abed HA, Abdelghany RS, Ahmed SH. Insulin Growth Factor-1 as a Predictor for the Progression of Hepatic Disease in Chronic Hepatitis B Virus Infection. TOBIOMJ 2021;11:1-7. [DOI: 10.2174/1875318302111010001] [Reference Citation Analysis]
|
| 24 |
Gençdal G, Yurdaydin C. Epidemiology of Hepatitis B Virus in the Middle East. Liver Cancer in the Middle East 2021. [DOI: 10.1007/978-3-030-78737-0_5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 25 |
Temraz S, Taher AT. An Overview of Hepatocellular Carcinoma (HCC) in Lebanon: A Focus on Hepatitis B- and Thalassemia-Related HCC. Liver Cancer in the Middle East 2021. [DOI: 10.1007/978-3-030-78737-0_24] [Reference Citation Analysis]
|
